Related Experiment Video

Updated: Jun 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Dose-response effects of TPI ASM8 in asthmatics after allergen

G M Gauvreau1, R Pageau, R Séguin

  • 1McMaster University, 1200 Main St West, Hamilton,Ontario, Canada. gauvreau@mcmaster.ca

Allergy
|May 25, 2011
PubMed
Abstract

Insights

TPI ASM8 effectively reduced airway inflammation and physiological changes in asthma patients following allergen challenge. This novel treatment demonstrated a dose-dependent response and is a promising therapeutic option for asthma management.

Area of Science:

  • Respiratory Medicine
  • Immunology
  • Pharmacology

Background:

  • TPI ASM8 is an antisense oligonucleotide (AON) therapy targeting IL-3, IL-5, GM-CSF receptors, and CCR3.
  • Previous research indicated TPI ASM8 may have effects beyond eosinophil inhibition in asthma.

Purpose of the Study:

  • To evaluate the dose-dependent effects of TPI ASM8 on inflammatory and physiological responses after inhaled allergen challenge (AIC) in mild allergic asthmatics.

Main Methods:

  • A single-center, open-label, dose-escalation study involving 14 mild allergic asthmatics.
  • Participants received escalating doses of inhaled TPI ASM8 (1, 2, 4 mg BID; 8 mg OD) after placebo AIC, with washout periods between treatments.

Main Results:

  • TPI ASM8 was safe and well-tolerated across all tested doses.
  • The 8 mg OD dose significantly reduced sputum eosinophils (up to 68.4%), attenuated early and late airway responses (45% and 59% reduction, respectively), decreased eosinophil cationic protein (ECP) by 57%, and improved airway responsiveness to methacholine.
  • A dose-response relationship was observed, with sustained efficacy at once-daily dosing.

Conclusions:

  • TPI ASM8 demonstrated significant efficacy in attenuating diverse inflammatory and physiological changes post-allergen challenge.
  • These findings suggest that targeting CCR3, IL-3, and GM-CSF pathways is crucial for effective asthma management.

More Related Videos

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma